CST3 Anticorps
(Cystatin C (CST3))
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes the most abundant extracellular inhibitor of cysteine proteases, which is found in high concentrations in biological fluids and is expressed in virtually all organs of the body. A mutation in this gene has been associated with amyloid angiopathy. Expression of this protein in vascular wall smooth muscle cells is severely reduced in both atherosclerotic and aneurysmal aortic lesions, establishing its role in vascular disease. [provided by RefSeq, Jul 2008].
Recommandation
CST3 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
Recommandation
Recommandation
CST3 Reactivité: Humain WB, IHC, IP, ICC Hôte: Souris Monoclonal C14 unconjugated
CST3 Anticorps par Grade
On trouve ici des CST3 Anticorps avec un Grade spécifique. Les Grade mentionnés ici sont quelques-uns de ceux qui sont disponibles. Un clic sur le lien correspondant permet d'accéder aux produits
CST3 Anticorps par Hote
On trouve ici des CST3 Anticorps avec un Hote spécifique. Les Hote mentionnés ici sont quelques-uns de ceux qui sont disponibles. Un clic sur le lien correspondant permet d'accéder aux produits
CST3 Anticorps par Clonalité
Trouvez les CST3 Anticorps monoclonaux ou polyclonaux disponibles. Cliquez sur un lien pour accéder aux produits correspondants.
CST3 Anticorps fréquemment utilisés
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (6)
N° du produit
ABIN7429547
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IF
Validations
- (1)
- (5)
N° du produit
ABIN3022135
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (4)
N° du produit
ABIN7425584
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (4)
N° du produit
ABIN7428170
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Mouse
Application
WB, IHC, IP, ICC
Validations
- (3)
N° du produit
ABIN7429550
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Pig
Application
WB, IHC, IP, ICC
Validations
- (3)
N° du produit
ABIN7432877
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC (p), IF
Validations
- (3)
N° du produit
ABIN7250317
Quantité
200 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA
Validations
- (2)
- (2)
N° du produit
ABIN969070
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Monkey, Mouse, Rat
Application
WB, ELISA, IHC, ICC, IF
Validations
- (3)
N° du produit
ABIN6261064
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IF
Validations
- (3)
N° du produit
ABIN1497755
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (2)
N° du produit
ABIN7148991
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human, Monkey, Mouse, Rat
Application
WB, ELISA
Validations
- (2)
N° du produit
ABIN3184215
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
ELISA, IHC
Validations
- (2)
N° du produit
ABIN7148973
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (2)
N° du produit
ABIN7237851
Quantité
200 μL
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Application
WB, IHC
Validations
- (2)
N° du produit
ABIN7256788
Quantité
200 μL
Fiche technique
Fiche technique
Dernières publications pour nos CST3 Anticorps
: "Investigation of the effects of hesperidin and chrysin on renal injury induced by colistin in rats." dans: Biomedicine & pharmacotherapy, Vol. 108, pp. 1607-1616, (2019) (PubMed).: "The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes." dans: Journal of leukocyte biology, Vol. 100, Issue 4, pp. 811-822, (2016) (PubMed).
: "The proteins interacting with C-terminal of μ receptor are identified by bacterial two-hybrid system from brain cDNA library in morphine-dependent rats." dans: Life sciences, Vol. 143, pp. 156-67, (2016) (PubMed).
: "Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients." dans: Scandinavian journal of rheumatology, Vol. 40, Issue 5, pp. 341-6, (2011) (PubMed).
: "Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages." dans: Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 31, Issue 5, pp. 560-6, (2011) (PubMed).
: "[Urinary cystatin C as a biomarker of renal tubular injury]." dans: Postȩpy higieny i medycyny doświadczalnej (Online), Vol. 65, pp. 562-8, (2011) (PubMed).
: "[Cystatin C level is independently related to risk of unfavorable outcome after acute coronary syndrome in individuals with normal or moderately reduced renal function]." dans: Kardiologiia, Vol. 51, Issue 6, pp. 4-10, (2011) (PubMed).
: "The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis." dans: American journal of epidemiology, Vol. 174, Issue 8, pp. 949-57, (2011) (PubMed).
: "Is cystatin C a useful marker in the detection of diabetic kidney disease?" dans: Nephron. Clinical practice, Vol. 114, Issue 2, pp. c127-34, (2010) (PubMed).
: "Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease." dans: Clinical chemistry, Vol. 56, Issue 5, pp. 740-9, (2010) (PubMed).
Pseudonymes pour CST3 Anticorps
cystatin C (CST3) Anticorpscystatin C L homeolog (cst3.L) Anticorps
cystatin C (amyloid angiopathy and cerebral hemorrhage) (cst3) Anticorps
cystatin C (cst3) Anticorps
cystatin 3 (cystatin 3) Anticorps
cystatin C (Cst3) Anticorps
armd11 Anticorps
ARMD11 Anticorps
CysC Anticorps
CYSC Anticorps
fb51d07 Anticorps
wu:fb24g06 Anticorps
wu:fb51d07 Anticorps
wu:fc55f03 Anticorps
zgc:136227 Anticorps
Avez-vous cherché autre chose?
- CST2 Anticorps
- CST11 Anticorps
- CST1 Anticorps
- CSRP3 Anticorps
- CSRP2BP Anticorps
- CSRP2 Anticorps
- CSRP1 Anticorps
- CSRNP3 Anticorps
- CSRNP2 Anticorps
- CSPP1 Anticorps
- CSPG5 Anticorps
- CSNK2B Anticorps
- CSNK2A2 Anticorps
- CSNK2A1/CK II alpha Anticorps
- CSNK1G3 Anticorps
- CSNK1G1 Anticorps
- CSNK1A1L Anticorps
- CSNK1A1 Anticorps
- CSN3 Anticorps
- CSN2 Anticorps
- CST4 Anticorps
- CST5 Anticorps
- CST6 Anticorps
- CST7 Anticorps
- CST8 Anticorps
- CST9 Anticorps
- CST9L Anticorps
- CSTA Anticorps
- CSTB Anticorps
- CSTF1 Anticorps
- CSTF2 Anticorps
- CSTF2T Anticorps
- CSTF3 Anticorps
- CSTL1 Anticorps
- CT47A1 Anticorps
- CTAG1A Anticorps
- CTAG1B Anticorps
- CTAG2 Anticorps
- CTAGE1 Anticorps
- CTAGE4 Anticorps
Vous êtes ici:
